Physician profile
Chen Shi
NPI 1013303049
$2,100.10
in general payments reported to CMS, 2019-2025
10 companies · $447 in 2025
The $447 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $1,515 · 2024: $139 · 2025: $447.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,470 · Travel and Lodging: $630.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,470.45 |
| Travel and Lodging | $629.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $928.03 | 2023-2025 | Sable, Orbit-R Anterior Lumbar Disc, Excelsiusgps Robotic Navigation System |
| Nuvasive, INC. | $351.02 | 2023 | Xlif, Tlif, Pcm |
| Alphatec Spine, INC | $300.00 | 2025 | Other - Miscellaneous |
| Stryker Corporation | $267.93 | 2023 | Avs Anchor-L, Everest Spinal System |
| Boston Scientific Corporation | $152.19 | 2023-2025 | Wavewriter Alpha Prime 16 |
| Providence Medical Technology, INC. | $27.63 | 2023 | |
| Baxter Healthcare | $21.29 | 2024 | Perclot |
| Medtronic, INC. | $20.31 | 2025 | Catalyft Pl Expandable Interbody System |
| Intrinsic Therapeutics | $16.70 | 2025 | Barricaid Acd (Annular Closure Device) |
| Theragen, INC. | $15.00 | 2025 | Actastim-S |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chen Shi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.